CASTRICONI, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 8.807
AS - Asia 948
NA - Nord America 476
SA - Sud America 75
AF - Africa 23
OC - Oceania 3
Totale 10.332
Nazione #
IT - Italia 8.631
US - Stati Uniti d'America 452
SG - Singapore 414
CN - Cina 243
VN - Vietnam 183
FR - Francia 66
BR - Brasile 43
HK - Hong Kong 36
FI - Finlandia 29
DE - Germania 23
GB - Regno Unito 16
JP - Giappone 14
AR - Argentina 13
MX - Messico 12
IN - India 10
BD - Bangladesh 7
CA - Canada 7
ID - Indonesia 7
CH - Svizzera 6
NL - Olanda 6
EC - Ecuador 5
ZA - Sudafrica 5
CL - Cile 4
IQ - Iraq 4
MA - Marocco 4
PH - Filippine 4
PY - Paraguay 4
AU - Australia 3
CO - Colombia 3
CR - Costa Rica 3
ES - Italia 3
OM - Oman 3
PK - Pakistan 3
PL - Polonia 3
RO - Romania 3
TR - Turchia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AO - Angola 2
AT - Austria 2
DZ - Algeria 2
JO - Giordania 2
LT - Lituania 2
MY - Malesia 2
NP - Nepal 2
PT - Portogallo 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
TN - Tunisia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
BF - Burkina Faso 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IE - Irlanda 1
KE - Kenya 1
LB - Libano 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
QA - Qatar 1
SE - Svezia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
Totale 10.332
Città #
Genova 5.089
Genoa 2.159
Rapallo 666
Vado Ligure 640
San Jose 192
Singapore 176
Ashburn 60
Lauterbourg 60
Ho Chi Minh City 55
Council Bluffs 44
Beijing 43
Hanoi 38
Hong Kong 34
Helsinki 27
Bordighera 24
New York 22
Frankfurt am Main 21
Santa Clara 19
Tokyo 12
Haiphong 10
Da Nang 8
Rome 8
Los Angeles 7
Mexico City 7
Milan 7
Orem 7
Tianjin 7
Amsterdam 6
Zurich 6
Bologna 5
Chicago 5
Jakarta 5
São Paulo 5
Biên Hòa 4
City of London 4
Des Moines 4
Hải Dương 4
Johannesburg 4
Paris 4
Thái Nguyên 4
Toronto 4
Cardiff 3
Dallas 3
Naples 3
Ninh Bình 3
Quảng Ngãi 3
Rio de Janeiro 3
San José 3
Sydney 3
Tashkent 3
Amman 2
Baghdad 2
Boa Vista 2
Bra 2
Brugnera 2
Buenos Aires 2
Can Tho 2
Cao Lanh 2
Changsha 2
Florence 2
Jingjiang 2
Kyoto 2
Lappeenranta 2
Luanda 2
Manchester 2
Miguel Hidalgo 2
Montreal 2
Nuremberg 2
Phủ Lý 2
Portico di Caserta 2
Rabat 2
Savona 2
Seeb 2
Shanghai 2
Thái Bình 2
Vĩnh Long 2
Vũng Tàu 2
Acaraú 1
Addis Ababa 1
Alberton 1
Alcanena 1
Alfreton 1
Annaba 1
Anápolis 1
Aryanah 1
Asunción 1
Athens 1
Atlanta 1
Avaré 1
Avellaneda 1
Baie-D'Urfé 1
Bangkok 1
Barcelona 1
Bari 1
Barquisimeto 1
Barra Bonita 1
Barra Mansa 1
Barranquilla 1
Basingstoke 1
Basra 1
Totale 9.610
Nome #
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 245
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 232
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 220
Main NK cell receptors and their ligands: regulation by microRNAs 219
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 212
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 209
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 200
Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells 184
Function and specificity of human natural killer cell receptors. 184
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 179
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells 179
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 175
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 172
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 172
Identification of NKp80, a novel triggering molecule expressed by human NK cells. 170
Human NK cells and NK receptors 168
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors 166
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 165
CIS is a negative regulator of IL-15-mediated signals in NK cells 165
Cell-laden hydrogel as a clinical-relevant 3D model for analyzing neuroblastoma growth, immunophenotype, and susceptibility to therapies 164
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 161
Cellular ligands for activating NK receptors 159
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. 159
Imatinib and nilotinib off-target effects on human NK cells, monocytes, and M2 macrophages 156
Overview of the Soluble and Membrane-bound Tumor Factors Limiting NKmediated Immune Surveillance 155
Natural killer lymphocytes: "null cells" no more. 154
Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1 153
Expression of the DNAM-1 ligands Nectin-2 (CD112) and poliovirus receptor (CD155) on dendritic cells: relevance for natural killer/dendritic cells interaction 152
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 149
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 148
Neuroblastoma-derived transforming growth factor (TGF) β1 modulates the chemokine receptor repertoire of human resting Natural Killer Cells. 147
TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells. 147
Pathogen-induced private conversations between natural killer and dendritic cells 144
Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects 142
Cytokine-induced expression of killer inhibitory receptors in human T lymphocytes 141
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells. 141
TGF-beta1 downregulates the expression of CX3CR1 by inducing miR-27a-5p in primary human NK cells 141
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 140
Neuroblastoma-Derived TGF-beta1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells. 139
The leukocyte Ig-like receptor (LIR)-1 for the Cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1+ NK cell clones 137
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin 135
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency 132
Identification of 4Ig-B7-H3 as a novel neuroblastoma-associated molecule that exerts a protective role from natural killer cell-mediated lysis 130
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 129
Neuroblastoma Cells Modulate Chemokine Receptor Repertoire of Resting NK Cells 128
New perspectives in glioma immunotherapy. 128
The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition 126
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule 126
A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model 125
Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies 125
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes (LDGL) 124
Shaping of adaptive immunity by innate interactions 123
Identification of a novel neuroblastoma-associated molecule that protects from NK-mediated lysis 123
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma 123
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 120
Therapeutic and diagnostic methods and compositions targeting 4IG-B7-H3 and its counterpart NK cell receptor 119
Natural Killer cells recognize and kill human glioblastoma cells with stem cell-like properties 115
Elementi di istologia e cenni di embriologia 115
ISTOLOGIA di Monesi 7 109
The SIICA School of Immunology 2017: a gathering for NGS (next generation scientists) 108
Su.64. Natural Killer Cell-mediated Recognition of Human Brain Tumors 107
Selective cross-talk among natural cytotoxicity receptors in human natural killers cells 105
B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma 100
TGFβ1 inhibits the surface expression of the NKp30 and NKG2D triggering NK receptors: consequences for the NK-mediated killing of dendritic cells 97
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants 90
Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants 88
High-dimensional single-cell analysis of human natural killer cell heterogeneity 80
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine /chemokine secretion in CD56(bright) and CD56(dim) NK cells 79
Surface NK receptors and their ligands on tumors cells 77
Inhibitory axes impacting on the activity and fate of Innate Lymphoid Cells 74
NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms 68
Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells 65
Membrane IL-18 identifies a human macrophage subset with distinct proteomic and functional traits 62
miR-24-3p down-regulates the expression of the apoptotic factors FasL and BIM in human natural killer cells 61
Editorial: Recent 3D Tumor Models for Testing Immune-Mediated Therapies 58
Editorial: TGF-β as a Key Regulator of NK and ILCs Development and Functions 48
Exosomes and immune modulation: implications for neuroblastoma immunotherapy 32
Natural killer cells and engagers: Powerful weapons against cancer 28
Immunomodulatory Mechanisms Impacting the Activity and Fate of Natural Killer Cells in Cancer 23
Totale 10.550
Categoria #
all - tutte 32.128
article - articoli 30.589
book - libri 657
conference - conferenze 344
curatela - curatele 0
other - altro 0
patent - brevetti 276
selected - selezionate 0
volume - volumi 262
Totale 64.256


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021156 0 0 0 0 0 0 0 0 0 76 29 51
2021/2022852 34 79 66 113 14 53 43 201 38 70 39 102
2022/2023820 81 72 11 85 126 144 3 60 147 6 69 16
2023/2024489 22 69 15 78 29 52 27 38 33 23 43 60
2024/20251.506 25 103 84 91 211 147 176 232 41 67 147 182
2025/20262.447 290 69 170 210 399 213 426 159 247 264 0 0
Totale 10.550